Serge Belanger
Stock Analyst at Needham
(4.46)
# 1,156
Out of 5,078 analysts
985
Total ratings
43.2%
Success rate
9.2%
Average return
Main Sectors:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Reiterated: Buy | $72 → $58 | $42.65 | +35.99% | 74 | Oct 14, 2026 | |
| PCRX Pacira BioSciences | Downgraded: Hold | n/a | $36.42 | - | 83 | Oct 8, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $112 | $61.23 | +82.92% | 55 | Oct 5, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $18 | $6.50 | +176.92% | 17 | Sep 28, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $78 → $60 | $35.34 | +69.78% | 41 | Sep 18, 2026 | |
| EVMN Evommune | Reiterated: Buy | $28 | $5.10 | +449.02% | 2 | Sep 9, 2026 | |
| BCRX BioCryst Pharmaceuticals | Reiterated: Buy | $16 | $7.65 | +109.15% | 59 | Sep 8, 2026 | |
| VRCA Verrica Pharmaceuticals | Reiterated: Hold | n/a | $3.53 | - | 49 | Aug 27, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $15 | $7.85 | +91.08% | 36 | Aug 13, 2026 | |
| OMER Omeros | Reiterated: Hold | n/a | $16.57 | - | 55 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $164 | $138.78 | +18.17% | 3 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.3028 | - | 62 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $11.85 | +153.16% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $25.14 | -20.45% | 45 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $19.71 | +143.53% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $7.90 | +381.01% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $12.61 | +82.39% | 52 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $31.20 | +28.21% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $46 | $22.96 | +100.35% | 168 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.01 | - | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $22.37 | +51.99% | 36 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.5669 | n/a | 9 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.23 | n/a | 13 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $1.25 | n/a | 1 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0067 | n/a | 2 | Jun 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $5 | $0.08484 | n/a | 3 | Aug 19, 2016 |
Liquidia
Oct 14, 2026
Reiterated: Buy
Price Target: $72 → $58
Current: $42.65
Upside: +35.99%
Pacira BioSciences
Oct 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $36.42
Upside: -
Cytokinetics
Oct 5, 2026
Reiterated: Buy
Price Target: $112
Current: $61.23
Upside: +82.92%
Ocular Therapeutix
Sep 28, 2026
Reiterated: Buy
Price Target: $18
Current: $6.50
Upside: +176.92%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $78 → $60
Current: $35.34
Upside: +69.78%
Evommune
Sep 9, 2026
Reiterated: Buy
Price Target: $28
Current: $5.10
Upside: +449.02%
BioCryst Pharmaceuticals
Sep 8, 2026
Reiterated: Buy
Price Target: $16
Current: $7.65
Upside: +109.15%
Verrica Pharmaceuticals
Aug 27, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.53
Upside: -
CorMedix
Aug 13, 2026
Reiterated: Buy
Price Target: $15
Current: $7.85
Upside: +91.08%
Omeros
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $16.57
Upside: -
Aug 12, 2026
Reiterated: Buy
Price Target: $164
Current: $138.78
Upside: +18.17%
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $0.3028
Upside: -
Aug 10, 2026
Reiterated: Buy
Price Target: $30
Current: $11.85
Upside: +153.16%
Aug 7, 2026
Reiterated: Hold
Price Target: $20
Current: $25.14
Upside: -20.45%
Aug 7, 2026
Reiterated: Buy
Price Target: $48
Current: $19.71
Upside: +143.53%
Aug 7, 2026
Reiterated: Buy
Price Target: $38
Current: $7.90
Upside: +381.01%
Aug 7, 2026
Reiterated: Buy
Price Target: $23
Current: $12.61
Upside: +82.39%
Aug 6, 2026
Rated: Buy
Price Target: $36 → $40
Current: $31.20
Upside: +28.21%
Aug 6, 2026
Reiterated: Buy
Price Target: $56 → $46
Current: $22.96
Upside: +100.35%
Aug 6, 2026
Reiterated: Hold
Price Target: n/a
Current: $7.01
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $34
Current: $22.37
Upside: +51.99%
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $0.5669
Upside: n/a
Oct 28, 2022
Rated: Hold
Price Target: n/a
Current: $1.23
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $22
Current: $1.25
Upside: n/a
Jun 26, 2017
Reiterated: Hold
Price Target: n/a
Current: $0.0067
Upside: n/a
Aug 19, 2016
Reiterated: Buy
Price Target: $11 → $5
Current: $0.08484
Upside: n/a